Recall Register

Food, drugs, devices › Philips Ultrasound Inc

Device recall: All EPIQ and Affiniti Ultrasound systems. Model numbers - EPIQ 5G, EPIC 5C, EPIQ 5W, EPIQ 7G, EPIC 7C, EPIQ 7W, EPIQ CVx

FDA enforcement event 86992 · Class II · initiated 27 Oct 2020 · status Terminated · terminated 19 Apr 2023

DeviceVoluntary: Firm initiated1 product recordBothell, WA

FDA enforcement event 86992 is a device recall by Philips Ultrasound Inc of Bothell, WA, initiated 27 Oct 2020 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 19 Apr 2023. Initiation: voluntary: firm initiated. Philips Ultrasound Inc has 22 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips Ultrasound Inc, Bothell, WA.

Reason for recall

"The manufacturer has determined that with certain uncommon workflows there is potential for incorrect patient data to be displayed and saved into an exam. The issue(s) manifest differently for different versions of software."

Distribution

"Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0864-2021All EPIQ and Affiniti Ultrasound systems. Model numbers - EPIQ 5G, EPIC 5C, EPIQ 5W, EPIQ 7G, EPIC 7C, EPIQ 7W, EPIQ CVx, Affiniti 30, Affiniti 50, Affiniti 70. Diagnostic Ultrasound System. MOD - EPIQ 5 GMDN - 40761 100-240V 50/60 Hz, 600 VA MOD - EPIQ 7 GMDN - 40761 100-240V 50/60 Hz, 600 VA MOD - EPIQ 100-240V…57,430 unitsClass IITerminated20 Jan 2021

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 2
22events on this register for the firm

Other enforcement events for Philips Ultrasound Inc

InitiatedProduct (first record)TypeClassRecords
5 Sep 2025Philips 3D6-2 Ultrasound TransducerDeviceClass III11
3 Jul 20253D6-2 Transducer ProbeDeviceClass III69
28 May 2025Philips 3D9-3v Transducer.DeviceClass II21
23 Mar 20245000 Compact Series Ultrasound Systems, Product/REF: 5500 CV/795141, 5500 P/795143, 5500 W/795144, 5500 G/795145, and PrDeviceClass II1
9 Oct 2023Philips EPIQ Diagnostic Ultrasound System Models: EPIQ 7G(model # 795200), EPIQ 7C (Model # 795201), EPIQ 7W (Model # 79DeviceClass II2
30 Jun 20233D9-3v Transducer, accessory to Philips Ultrasound Systems: EPIQ Elite; Affiniti 30, 50, and 70; ClearVue 850; HD15; iU2DeviceClass II1
21 Sep 2021EPIQ CVxi Diagnostic Ultrasound Systems, Product Code: 795232DeviceClass II1
19 Aug 2021Philips Ultrasound, Inc. Sparq, Diagnostic Ultrasound System, REF 795090, 100-240V -, 50/60 Hz, 500 VA, CE2797, Rx Only,DeviceClass II2
6 Aug 2021EPIQ Diagnostic Ultrasound Systems: Software Versions 5.0, 5.0.1 and 5.0.2 Models: EPIQ 5 - 795120 EPIQ 5C - 795205 EPIQDeviceClass II2
22 Jul 2021EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EPIQ CVx, EPIQ CVxiDeviceClass II1

All 22 events for Philips Ultrasound Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The manufacturer has determined that with certain uncommon workflows there is potential for incorrect patient data to be displayed and saved into an exam. The issue(s) manifest differently for different versions of software."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 19 Apr 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.